Arkolith/Insider Trading/CATX/Form 4

Williamson Robert F III

DirectorPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Jun 3, 2024
Net Buying
Open-Market Buys
$76K
Open-Market Sells
$0
Net Open-Market Flow
$76K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2024Buy(P)55K$1.38$76K424K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-067945) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML